Publication Name	World Journal of Gastroenterology
Manuscript ID	9733
Country	Italy

Received	2014-03-02 19:57
Peer-Review Started	2014-03-07 08:48
To Make the First Decision	2014-03-27 20:58
Return for Revision	2014-03-31 10:22
Revised	2014-05-27 00:00
Second Decision	2014-06-26 16:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-26 17:40
Articles in Press	2014-06-26 17:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-17 16:52
Publish the Manuscript Online	2014-12-02 10:46

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?
Manuscript Source	Unsolicited Manuscript
All Author List	Carmine Finelli, Maria Carmela Padula, Giuseppe Martelli and Giovanni Tarantino
Funding Agency and Grant Number
Corresponding Author	Giovanni Tarantino, MD, Senior Clinical Investigator, Past Adjunct Professor of Internal Medicine, Department of Clinical Medicine and Surgery, Federico II University Medical School of Naples, Via Sergio Pansini, 5, 80131 Naples, Italy. tarantin@unina.it
Key Words	Obesity; Bariatric surgery; Gut hormones; Nonalcoholic fatty liver disease; Microbiome
Core Tip	It is important to emphasize the role of the major peptides released by the enteroendocrine system, which promote satiety and modulate energy homeostasis and utilization, as well as those that control fat absorption and intestinal permeability. Bariatric surgery could be the most effective treatment for obesity and co-morbidities, often within days after surgery, independently of weight loss and it is currently the only therapy available for obesity which results in long-term, sustained weight loss. We hypothesize that gut hormones might play a role in induction and long-term maintenance of weight loss, could determine the improvement of obesity-related co-morbidities and could help to identify new drug targets and improved surgical techniques.
Publish Date	2014-12-02 10:46
Citation	Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol 2014; 20(44): 16649-16664
URL	http://www.wjgnet.com/1007-9327/full/v20/i44/16649.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i44.16649

Full Article (PDF)	WJG-20-16649.pdf
Full Article (Word)	WJG-20-16649.doc
Manuscript File	9733-Review .doc
Answering Reviewers	9733-Answering Reviewers.pdf
Copyright License Agreement	9733-Copyright Assignment.pdf
Peer-review Report	9733-Peer reviews.pdf
Scientific Misconduct Check	9733-CrossCheck.jpg
Scientific Editor Work List	9733-Scientific editor work list.pdf